WR-1065
Suppliers
Names
[ CAS No. ]:
14653-77-1
[ Name ]:
WR-1065
[Synonym ]:
Ethanethiol, 2-[(3-aminopropyl)amino]-, hydrochloride (1:1)
2-(3-aminopropylamino)ethanethiol,dihydrochloride
2-[(3-Aminopropyl)amino]ethanethiol hydrochloride (1:1)
2-[(3-Aminopropyl)amino]ethanethiol dihydrochloride WR-1065 dihydrochloride
WR-1065 dihydrochloride
Chemical & Physical Properties
[ Density]:
0.975g/cm3
[ Boiling Point ]:
218.6ºC at 760 mmHg
[ Molecular Formula ]:
C5H16Cl2N2S
[ Molecular Weight ]:
207.16
[ Flash Point ]:
86ºC
[ PSA ]:
76.85000
[ LogP ]:
1.74780
[ Vapour Pressure ]:
0.124mmHg at 25°C
[ Index of Refraction ]:
1.496
[ Storage condition ]:
2-8℃
MSDS
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- KJ0203000
- CHEMICAL NAME :
- Ethanethiol, 2-((3-aminopropyl)amino)-, dihydrochloride
- CAS REGISTRY NUMBER :
- 14653-77-1
- LAST UPDATED :
- 199707
- DATA ITEMS CITED :
- 1
- MOLECULAR FORMULA :
- C5-H14-N2-S.2Cl-H
- MOLECULAR WEIGHT :
- 207.19
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 400 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- EJMCA5 European Journal of Medicinal Chemistry--Chimie Therapeutique. (Editions Scientifiques Elsevier, 29 rue Buffon, F-75005, Paris, France) V.9- 1974- Volume(issue)/page/year: 24,48,1989
Safety Information
[ Symbol ]:
GHS05, GHS07
[ Signal Word ]:
Danger
[ Hazard Statements ]:
H302-H318
[ Precautionary Statements ]:
P280-P305 + P351 + P338
[ RIDADR ]:
NONH for all modes of transport
Articles
Radiat. Res. 179(2) , 115-24, (2013)
Very low doses of ionizing radiation, 5 to 100 mGy, can induce adaptive responses characterized by elevation in cell survival and reduction in micronuclei formation. Utilizing these end points, RKO hu...
Oncogene 24(24) , 3964-75, (2005)
The aminothiol WR1065 exerts selective cytoprotective effects in normal cells compared to cancer cells and has clinical applications for the protection of normal cells in cancer patients undergoing ra...
Clin. Cancer Res. 16(3) , 1049-57, (2010)
We evaluated the pharmacokinetics of amifostine and WR1065 in pediatric patients with newly diagnosed medulloblastoma to assess the influence of patient covariates, including demographics, clinical ch...